The National Institutes of Health (NIH) defines a clinical trial as a research study in which one or more human subjects are prospectively assigned to one or more interventions. Clinical trials help develop novel drugs (Investigational Products) by providing early access to patients who volunteer to participate in the research study.

Our expert Providers participate in the observational clinical trials* listed below. The eligibility criteria described in the trial information enables patients with advanced solid tumors to access these Investigational Products. In addition to sponsoring our own clinical trial, BioCytics also participates in externally sponsored biopharma trials. Please view the list of trials below that are currently enrolling patients:

*Characterization of a patient group.

Internally Sponsored Trials

Title: A Study to Facilitate Development of an Ex-Vivo Device Platform for Circulating Tumor Cell and Immune Cell Harvesting, Banking, and Apoptosis-Viability Assay

Recruitment Status: Recruiting

Clinicaltrials.gov Link

Status: In Development

Status: In Development

Externally Sponsored Trials

Title: Collection of Whole Blood and Tissue Specimens From Patients Diagnosed With Non-Hematologic Cancer for Use in Development of a Noninvasive Liquid Biopsy Assay to Determine the Tumor Genomic Profile in Circulating Cell-Free Tumor DNA

Recruitment Status: Recruiting

Clinicaltrials.gov Link